Is BRCA1 p.Arg1495Trp (c.4483A>T) pathogenic?

BRCA1 p.Arg1495Trp (c.4483A>T) is classified Uncertain significance in BRCA1 (ClinVar, Single submitter, 1 submitter; last evaluated 2023-02-14). AlphaMissense: likely benign (0.1593); Absent from gnomAD v4.1; Associated with hereditary breast ovarian cancer syndrome.

What condition is associated with BRCA1 p.Arg1495Trp (c.4483A>T)?

BRCA1 p.Arg1495Trp (c.4483A>T) is associated with hereditary breast ovarian cancer syndrome (ClinVar).

How common is BRCA1 p.Arg1495Trp (c.4483A>T) in the general population?

BRCA1 p.Arg1495Trp (c.4483A>T) is absent from gnomAD v4.1 (gnomAD).

How is Hereditary breast and/or ovarian cancer syndrome inherited?

Typically Autosomal dominant (Orphanet). A genetic counselor can assess individual risk for a family.

What do computational predictors say about BRCA1 p.Arg1495Trp (c.4483A>T)?

AlphaMissense predicts likely benign (score 0.1593) — an in-silico prediction, not a clinical call.

BRCA1 p.Arg1495Trp

c.4483A>T · rs2551618798 · VCV2836927

Uncertain significance Single submitter

Classification

Uncertain significance

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 1 submitter

AlphaMissense

likely benign

0.1593 · ACMG-weighted

gnomAD v4.1

Absent

absent from gnomAD v4.1

Missense predictors

1/3 damaging

AlphaMissense, REVEL, SaProt

Conditions

hereditary breast ovarian cancer syndrome

Computational evidence

Protein change
AlphaMissense	0.1593	likely benign
REVEL	0.65	pathogenic-leaning
SaProt	LLR -8.21	tolerated
⇒ REVEL calls this damaging; AlphaMissense and SaProt do not.
Splicing
SpliceAI	<0.2	all four deltas below 0.2 · T>C here scores Δ0.20 · evaluated, not missing
Constraint at this position
Conservation	phyloP 0.23	GERP -1.9, phastCons 0.92
Regional constraint	o/e 0.91	unconstrained · MANE · 78 kb · p 4.8e-05 · regional, not allelic
Overall
CADD	24.4	PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.

Variant & gene context

Gene: BRCA1
Protein: p.Arg1495Trp
Coding: c.4483A>T
MANE Select: NM_007294
dbSNP: rs2551618798
Type: single nucleotide variant
Location: chr17:43076489 (GRCh38)
Gene constraint: LOEUF 0.885 · pLI <0.01 · ClinGen HI 3/3 (gnomAD)
Structure: AlphaFold pLDDT 41.99 · 33 PDB
Residue 1495: the 'disordered' region; a UniProt-annotated variant site (in fancs); a UniProt-annotated variant site (in bc)

Full BRCA1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary breast ovarian cancer syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Hereditary breast and/or ovarian cancer syndrome (Orphanet):

Inheritance: Autosomal dominant
Onset: Adult, Elderly

Similar variants

BRCA1 p.Arg1495Thr Pathogenic ★★★ ⚠ same residue
BRCA1 p.Arg1495Lys Pathogenic ★★ ⚠ same residue
BRCA1 p.Arg1495Met Pathogenic ★★ ⚠ same residue
BRCA1 p.Arg1495fs Pathogenic ★★★ same residue
BRCA1 p.Arg1495Gly Uncertain significance ★ ⚠ same residue
BRCA1 p.Arg1495Ser Uncertain significance ★ ⚠ same residue
BRCA1 c.134+3A>T Likely pathogenic ★★★ same condition
BRCA1 c.135-1G>T Pathogenic ★★★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/brca1-p-arg1495trp (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown